Palisade Capital Management


A fundamentally different
way to invest.

As an independent asset manager established in 1995, Palisade Capital Management thinks, invests, and treats our clients in a manner that is fundamentally different from other managers. We believe in putting clients first, constant communication, fundamental research — and much more.

We invite you to see the difference being different can make:

Investment Teams

Growth Equity

Palisade’s six-member Growth Equity team, led by Senior Portfolio Managers Sammy Oh and Will Potter, employs a collaborative approach and has unique experience in the post-venture growth continuum. Utilizing intensive company-specific fundamental research, the team has navigated our clients’ Small Cap Growth, Smid Cap Growth, and Mid Cap Growth Equity portfolios through multiple investment cycles. Palisade’s Growth Equity portfolios are available through separately managed accounts, subadvised mutual fund engagements, a collective investment trust, and various wrap, SMA, and UMA platforms.

Investment Teams

Small Cap Core Equity

Led by Senior Portfolio Manager Marc Shapiro, Palisade’s experienced four-member Small Cap Core Equity team utilizes a research-intensive, disciplined investment process that integrates bottom-up fundamental stock research with a conviction-weighted approach to portfolio construction. This patient investment approach seeks outperformance regardless of market environment. Palisade’s Small Cap Core Equity portfolios are available through separately managed accounts, subadvised mutual fund engagements, a collective investment trust, and various wrap, SMA and UMA platforms.

Learn More

Investment Teams

Convertible Securities

Palisade's six-member Convertible Securities team, led by Senior Portfolio Manager Elliot Stiefel, CFA, and Portfolio Manager Bill Lee, is responsible for managing our clients' Convertible Securities and Convertible Arbitrage portfolios. This team's average individual experience of 27 years each in the investment industry, discipline throughout all market cycles, and strong equity research help distinguish it from other managers. Palisade's Convertible Securities portfolios are available through separately managed accounts, subadvised mutual fund engagements, and various SMA platforms, while our Convertible Arbitrage strategy is available through a private fund and separately managed accounts.

Investment Teams

Private Wealth Management

Private Wealth Management has served as a cornerstone of Palisade’s business since the firm’s founding in 1995. Our highly experienced team of Private Wealth Portfolio Managers average over three decades each of building and managing diversified portfolios for individuals, families, and organizations. Each manager works directly with clients to understand their individual financial needs, expectations, and goals, and then designs a portfolio that fits these unique circumstances.

Learn More

Investment Teams

Long Short Equity

Palisade’s Long Short Equity strategy is led by Portfolio Manager Paul Flather and primarily focuses on US small- and mid-capitalization stocks that have limited research coverage. Paul Flather has spent the past 19 years developing original research, performing field work, and conducting independent analysis, which he uses to seek alpha generation on both long and short positions. Palisade’s Long Short Equity strategy is available through a private fund and separately managed accounts.

Learn More

Investment Teams

Private Equity

Since 1997, Palisade has raised four private equity funds totaling over $400 million in capital. Our Private Equity funds seek to achieve attractive total returns through investments in small-to middle-market private and out-of-favor small public companies that represent “special situations” or growth opportunities. Palisade’s private equity funds are currently fully invested and are no longer open to new investors.

Investment Teams

News & Insight

Tuesday, February 03, 2015
PCEPII Portfolio Company Brickell Biotech Announces $10M Series C Financing, Initiates Phase 2b Study of BBI-4000 in Patients with Axillary Hyperhidrosis, and Acquires Novel, Clinical-Stage Compound for the Oral Treatment of Atopic Dermatitis
Posted in Private Equity News
Brickell Biotech, Inc. (“Brickell”), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced a $10 million Series C financing round (the “Offering”). Brickell’s pipeline includes new molecular entities in dermatology for hyperhidrosis, atopic dermatitis, and acne.
Monday, January 12, 2015
Q4 2014 Investor Commentary
Posted in Market Commentaries
As we write this letter, the stock market is experiencing one of its periodic swoons. Since the last day of 2014, the S&P 500® has dropped five of the last seven trading days. Market commentators are pinning much of the blame on the falling price of oil, which now hovers at $45 per barrel (West Texas intermediate grade oil quoted on the New York Mercantile Exchange). Oil has dropped 20 of the last 30 trading days since OPEC’s pivotal Vienna meeting on Thanksgiving Day (November 27). Suddenly analysts are saying, in a twist of Mae West’s famous aphorism, “Too much of a good thing may not be so wonderful after all.”
Read More
Wednesday, November 19, 2014
PPPII Portfolio Company QualityHealth Acquired by Sharecare
Posted in Private Equity News
Sharecare, a comprehensive health and wellness engagement platform, today announced the acquisition of QualityHealth, a platform for identifying patients at large scale, and activating them to take relevant health-specific actions. As one of the industry’s largest permission-based databases, QualityHealth has more than 50 million registered members and touches 100 million health consumers each month across 175 different health, wellness and therapeutic categories. PPPII will continue to own Sharecare equity post-closing.

View all Recent News & Insight

Latest Research and White Papers
Thursday, July 25, 2013
The Incredible Shrinking Stock Market and the Case for Small Cap Investing
On July 25, 2013 Palisade Capital Management published Chief Investment Officer – Institutional Dennison “Dan” T. Veru’s white paper entitled “The Incredible Shrinking Stock Market and the Case for Small Cap Investing”, which outlines Dan’s thoughts on small cap investing in the current market environment. Contact us today for a free copy of this report.
Find Out More and Request This White Paper

We Believe…

Learn more about Who We Are



…in comprehensive, bottom-up fundamental research - analyzing the numbers, visiting facilities, interviewing management teams, evaluating customer experiences, and performing channel checks.


…collaboration is critical to superior investment outcomes. Our team-oriented culture creates a constant flow of ideas and information across the firm that benefits every client.


…there is no substitute for a rigorous valuation discipline. We initiate positions based on our conviction to an investment thesis and continually challenge and review this thesis with a strict and unemotional buy/sell discipline.


…personal attention is essential to lasting client relationships. Our ongoing dialogue with our clients provides opportunities for both parties to share in—and shape—a successful investment outcome.

Connect with Us

One Bridge Plaza, Suite 695, Fort Lee, New Jersey 07024 | (201) 585-7733 | (800) 330-9966 | Get Directions | Contact Us

Stay Informed

Sign up for our mailing list and stay up to date on the latest information and news from Palisade Capital Management.